| Jun 24 |
Clarivate Launches IP Collaboration Hub
|
| Jun 20 |
Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports
|
| Jun 19 |
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
|
| Jun 4 |
Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas
|
| May 31 |
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
|
| May 30 |
Clarivate Announces Conversion Date and Conversion Rate for Series A Mandatory Convertible Preferred Shares
|
| May 30 |
Clarivate Plc: Still A Buy, But Recovery Could Take Longer Than Expected
|
| May 30 |
Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace Solution
|
| May 29 |
Clarivate to Present at Upcoming Investor Conferences in June 2024
|
| May 22 |
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
|
